Skip to content
  • Saturday, 12 September 2026
  • 6:29 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Archive by category "Pharmaceutical R&D"
Pharmaceutical R&D

Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to Diagnostics

Teuku Ryan Jul 22, 2026 0

The landscape of Alzheimer’s disease (AD) research and treatment is undergoing a significant transformation, marked by the recent advent of…

Read More
Pharmaceutical R&D

Japan Emerges as a Global Powerhouse for Regenerative Medicine Innovation

Teuku Ryan Jul 22, 2026 0

Japan is rapidly solidifying its position as a premier destination for regenerative medicine research and development, a surge driven by…

Read More
Pharmaceutical R&D

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Advertising of Obesity Drugs

Teuku Ryan Jul 21, 2026 0

The escalating rivalry between pharmaceutical giants Novo Nordisk and Eli Lilly has reached a new legal frontier, with Novo Nordisk…

Read More
Pharmaceutical R&D

AI Can Accelerate Study-Build Foundations, But Only When Teams Combine Targeted Automation with Standards, Traceability and Control.

Teuku Ryan Jul 21, 2026 0

Artificial intelligence (AI) is rapidly transforming various sectors, and clinical data management is no exception. While the potential applications of…

Read More
Pharmaceutical R&D

Samsung Biologics to Acquire PolyPeptide Group for SFr1.46 Billion, Expanding Peptide Therapeutics and CDMO Capabilities

Teuku Ryan Jul 21, 2026 0

Samsung Biologics has announced its intent to acquire PolyPeptide Group, a leading contract development and manufacturing organization (CDMO) specializing in…

Read More
Pharmaceutical R&D

New Therapies Usher in Era of Personalised Treatment for Rare Blood Cancers

Teuku Ryan Jul 21, 2026 0

A significant advancement in the treatment of rare blood cancers is set to transform the lives of approximately 200 patients…

Read More
Pharmaceutical R&D

The Inaugural EU Joint Clinical Assessment: Ojemda Sets Precedent Amidst Access Uncertainties

Teuku Ryan Jul 20, 2026 0

The European Union’s landmark Joint Clinical Assessment (JCA) for Ipsen’s orphan-designated drug Ojemda (tovorafenib) has been published, marking a significant…

Read More
Pharmaceutical R&D

Eli Lilly Acquires AtaiBeckley for $2.8 Billion, Marking Entry into Psychedelic Therapeutics

Teuku Ryan Jul 20, 2026 0

In a landmark move that signals a significant shift in pharmaceutical investment, Eli Lilly and Company has announced the acquisition…

Read More
Pharmaceutical R&D

Novo Nordisk Secures European Approval for Oral Wegovy, Bolstering First-Mover Advantage in Obesity Pill Market

Teuku Ryan Jul 20, 2026 0

Novo Nordisk has solidified its pioneering position in the burgeoning market for oral obesity medications with the European Commission’s marketing…

Read More
Pharmaceutical R&D

UK Recommends Routine Meningitis B Vaccination for Adolescents Following Data Review

Teuku Ryan Jul 19, 2026 0

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has put forth a significant recommendation for the introduction of a…

Read More

Posts pagination

1 2 3 4 … 33
Quantum sensor breakthrough could reveal dark matter and ancient gravitational wavesFDA Reverses Course, Agrees to Review Moderna’s mRNA Flu VaccineAntimatter Transported by Truck for the First Time Across CERN GroundsKaggle and Google Launch Free Generative AI Course, Setting World Record for Virtual AI Education
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum InformationSolstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy PorustobartScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026
Pharmaceutical R&D
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Teuku Ryan Sep 12, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ